Publications

Journal Title Author(s) Volume/Page Year of Publication
Supplementation with all three macular carotenoids: response, stability and safety Connolly, E.E, Beatty, S, Loughman, J, Howard, A, Louw, M, Nolan, JM 11-8025 2011
26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition Biesalski HK, J Aggett P, Anton R, Bernstein PS, Blumberg J, Heaney RP, Henry J, Nolan JM, Richardson DP, van Ommen B, Witkamp RF, Rijkers G 2010
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing. Nolan JM, Kenny R, O'Regan C, et al. 44:131-139 2010
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study Connolly EE, Beatty S, Thurnham DI, et al 35:335-351 2010
A central dip in the macular pigment spatial profile is associated with age and smoking Kirby ML, Beatty S, Loane E, et al 51:6722-6728 2010
Studies on the singlet oxygen scavenging mechanism of human macular pigment Li B, Ahmed F, Bernstein PS 504(1):56-60 2010
Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products Perry A, Rasmussen H, Johnson EJ 22:9-15 2009
The rationale and evidence base for a protective role of macular pigment in age-related maculopathy Loane E, Kelliher C, Beatty S, Nolan JM 92:1163-1168 2008
A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R,3'R)-zeaxanthin and (3R,3'R,6'R)-lutein. Thurnham DI, Tremel A, Howard AN. 1-8.:1-8 2008
A review of dietary sources and bioavailability and some relationships with macular pigment optical Thurnham DI 20:163-179 2007
Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Nolan JM, Stack J, O' DO, Loane E, Beatty S. 84:61-74 2007
Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula Bhosale P, Zhao dY, Serban B, Bernstein PS 48:1435-1440 2007
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin Bone RA, Landrum JT, Cao Y, Howard AN, varez-Calderon F 4:12.:12 2007
Salmonella-Escherichia coli/Mammalian-microsome reverse mutation assay with a confirmatory assay with mesozeaxanthin Mecchi MS 1-27 2006
Thirteen-week oral (gavage) toxicity of mesozeaxanthin in Han Wistar rats with a 4-week recovery Chang CJG 1-344 2006
Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation Bhosale P, Bernstein PS 1740:116-121 2005
Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM 46:692-702 2005
Identification and Characterization of a Pi Isoform of Glutathione S-Transferase (GSTP1) as a Zeaxanthin-binding Protein in the Macula of the Human Eye. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS 279:49447-49454 2004
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Kassoff A, The AREDS research group 119:1417-1436 2001
Stereochemistry of the Human Macular Carotenoids Bone RA, Landrum JT, Hime GW, Cains A, Zamor J 34:2033-2040 1993
The first isolation of enantiomeric and meso-zeaxanthin in nature Maoka T, Arai A, Shimizu M, Matsuno T 83:121-124 1986
The Macular Pigment .1. Absorbance Spectra, Localization, and Discrimination from Other Yellow Pigments in Primate Retinas Snodderly DM, Brown PK, Delori FC, Auran JD 25:660-673 1984
A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Sabour-Pickett S, Nolan JM, Loughman J, Beatty S. doi: 10.1002/mnfr.201100219 2011